Developer docs
API playgroundTry for free, no card

Search company profiles

MedSource

Full company profile

uuid000igmu

Namestring
MedSource
Websiteurl
medsource.com
Company typeenum
Private
Founded yearint
1997
Descriptiontext

MedSource is a private pharmaceutical services company headquartered in Houston, Texas, founded in 1997. The firm operates with 51-100 employees and is classified as a for-profit private entity. Based on its leadership composition, which includes senior directors of clinical operations and scientific development, MedSource appears to provide clinical research and pharmaceutical services to sponsors, operating in a manner consistent with a mid-sized contract research organization (CRO) or related services provider.

The company's organizational structure reflects a services-oriented operating model: it maintains dedicated business development leadership (VP of Business Development), proposal and contract management (Director of Proposals & Contracts), clinical operations, scientific development, and operational management. This indicates a project-based, contract-driven engagement model typical of pharmaceutical services firms serving drug developers and life sciences clients. However, the source data contains no specific information on product lines, service offerings, technology platforms, pricing, customer segments, or geographic coverage.

Business model mechanics — including how revenue is generated, contract structures, pricing models, and customer relationships — are not documented in the available source material. Multiple source pages returned only placeholder/verification content, creating a substantial data gap around commercial operations, financials, and strategic positioning. As a result, this description is limited to firmographic and leadership-based inferences and should be treated as preliminary.

Short descriptiontext

MedSource is a private Houston-based pharmaceutical services company founded in 1997, with 51-100 employees. It appears to provide clinical research and pharmaceutical services to drug development sponsors, based on its leadership in clinical operations and scientific development.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical services, clinical research services, drug development services, contract research services, clinical operations
Industry2 codes
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Health Services8000
Product category
Pharmaceutical Services
Social media profiles2 records
Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MedSource is a pharmaceutical services company providing clinical operations, business development, proposals and contracts, and scientific development support to clients in the pharmaceutical industry. Founded in 1997 and headquartered in Houston, United States, the firm operates with a 51-100 employee base delivering specialized pharmaceutical services.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Pharmaceutical Services
CategoryPharmaceutical Services
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-to-large CRO offering full-service clinical trial management with a similar sponsor mix of small-to-mid biopharma. Medpace is the most directly comparable publicly traded mid-size CRO to MedSource in terms of operating model and target customer segment.

TypeDirect peer
Description

UK-based CRO with US operations and a long history in clinical research and pharmacovigilance services. The ergomedcro.com URL appearing in MedSource's data record and overlapping clinical-operations focus make Ergomed a direct comparable for both service line and likely corporate relationship.

TypeDirect peer
Description

Mid-size global CRO focused on Phase II–IV trials, particularly in neuroscience, cardiometabolic, and rare disease — directly comparable to MedSource in size, therapeutic scope, and mid-biotech sponsor base.

TypeDirect peer
Description

Mid-size CRO offering full-service clinical operations to emerging and mid-sized biopharma. Comparable in size, geographic footprint, and operational model to MedSource.

TypeBroad incumbent
Description

Largest global CRO and life sciences services firm, with end-to-end clinical operations, technology, and data capabilities. Relevant as the dominant incumbent against which MedSource competes for mid-biotech study work.

TypeBroad incumbent
Description

Large global CRO with a strong biopharma sponsor book and broad therapeutic coverage. Comparable at the incumbent level and a relevant acquirer/competitor dynamic for a mid-size CRO like MedSource.

TypeDirect peer
Description

Specialty CRO with similar headcount and concentration on small-to-mid biopharma, including analgesia, oncology, and rare disease. Highly comparable in scale and customer profile to MedSource.

TypeBroad incumbent
Description

Large clinical and commercial services firm serving biopharma. Competes with MedSource in clinical operations RFPs and provides a useful reference point on broader industry economics and consolidation trends.

TypeBroad incumbent
Description

Top-three global CRO offering clinical operations, FSP, and laboratory services. Sets the competitive ceiling on full-service mid-size CRO deals and represents a likely acquirer profile for firms like MedSource.

TypeBroad incumbent
Description

Large clinical CRO spun out of Labcorp. Competes for the same mid-to-large sponsor work as MedSource and is a benchmark for clinical-operations scale and capability.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MedSource

Pharmaceutical Servicesmedsource.com

MedSource is a private Houston-based pharmaceutical services company founded in 1997, with 51-100 employees. It appears to provide clinical research and pharmaceutical services to drug development sponsors, based on its leadership in clinical operations and scientific development.

What MedSource does

MedSource is a private pharmaceutical services company headquartered in Houston, Texas, founded in 1997. The firm operates with 51-100 employees and is classified as a for-profit private entity. Based on its leadership composition, which includes senior directors of clinical operations and scientific development, MedSource appears to provide clinical research and pharmaceutical services to sponsors, operating in a manner consistent with a mid-sized contract research organization (CRO) or related services provider.

The company's organizational structure reflects a services-oriented operating model: it maintains dedicated business development leadership (VP of Business Development), proposal and contract management (Director of Proposals & Contracts), clinical operations, scientific development, and operational management. This indicates a project-based, contract-driven engagement model typical of pharmaceutical services firms serving drug developers and life sciences clients. However, the source data contains no specific information on product lines, service offerings, technology platforms, pricing, customer segments, or geographic coverage.

Business model mechanics — including how revenue is generated, contract structures, pricing models, and customer relationships — are not documented in the available source material. Multiple source pages returned only placeholder/verification content, creating a substantial data gap around commercial operations, financials, and strategic positioning. As a result, this description is limited to firmographic and leadership-based inferences and should be treated as preliminary.

MedSource firmographics

Firmographics
Name
MedSource
Website
https://medsource.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
51–100 employees
Short description
MedSource is a private Houston-based pharmaceutical services company founded in 1997, with 51-100 employees. It appears to provide clinical research and pharmaceutical services to drug development sponsors, based on its leadership in clinical operations and scientific development.
Ownership category
akta.pro rank

MedSource industry classification

Industry
Product category
Pharmaceutical Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Pharmaceutical services
  • Clinical research services
  • Drug development services
  • Contract research services
  • Clinical operations

Where MedSource is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Markets served

MedSource business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

MedSource product offering

Product offering

Core offering

MedSource is a pharmaceutical services company providing clinical operations, business development, proposals and contracts, and scientific development support to clients in the pharmaceutical industry. Founded in 1997 and headquartered in Houston, United States, the firm operates with a 51-100 employee base delivering specialized pharmaceutical services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Services

Companies that use MedSource

Customer profile

Ideal customer profiles1 record

MedSource technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MedSource partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights1 record

MedSource competitors and assessment

Company assessment

Direct peers

  • Medpace Holdings: Mid-to-large CRO offering full-service clinical trial management with a similar sponsor mix of small-to-mid biopharma. Medpace is the most directly comparable publicly traded mid-size CRO to MedSource in terms of operating model and target customer segment.
  • Ergomed: UK-based CRO with US operations and a long history in clinical research and pharmacovigilance services. The ergomedcro.com URL appearing in MedSource's data record and overlapping clinical-operations focus make Ergomed a direct comparable for both service line and likely corporate relationship.
  • Worldwide Clinical Trials: Mid-size global CRO focused on Phase II–IV trials, particularly in neuroscience, cardiometabolic, and rare disease — directly comparable to MedSource in size, therapeutic scope, and mid-biotech sponsor base.
  • Clinipace Worldwide (now d/b/a Caidya): Mid-size CRO offering full-service clinical operations to emerging and mid-sized biopharma. Comparable in size, geographic footprint, and operational model to MedSource.
  • Premier Research: Specialty CRO with similar headcount and concentration on small-to-mid biopharma, including analgesia, oncology, and rare disease. Highly comparable in scale and customer profile to MedSource.

Broad incumbents

  • IQVIA: Largest global CRO and life sciences services firm, with end-to-end clinical operations, technology, and data capabilities. Relevant as the dominant incumbent against which MedSource competes for mid-biotech study work.
  • Parexel International: Large global CRO with a strong biopharma sponsor book and broad therapeutic coverage. Comparable at the incumbent level and a relevant acquirer/competitor dynamic for a mid-size CRO like MedSource.
  • Syneos Health: Large clinical and commercial services firm serving biopharma. Competes with MedSource in clinical operations RFPs and provides a useful reference point on broader industry economics and consolidation trends.
  • ICON plc: Top-three global CRO offering clinical operations, FSP, and laboratory services. Sets the competitive ceiling on full-service mid-size CRO deals and represents a likely acquirer profile for firms like MedSource.
  • Labcorp Drug Development (now Fortrea): Large clinical CRO spun out of Labcorp. Competes for the same mid-to-large sponsor work as MedSource and is a benchmark for clinical-operations scale and capability.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

MedSource social profiles

Digital presence

MedSource financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MedSource leadership team

Management profile

Number of profiles

Profiles7 records

MedSource funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MedSource M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedSource

What does MedSource do?

MedSource is a pharmaceutical services company providing clinical operations, business development, proposals and contracts, and scientific development support to clients in the pharmaceutical industry. Founded in 1997 and headquartered in Houston, United States, the firm operates with a 51-100 employee base delivering specialized pharmaceutical services.

Is MedSource a public or private company?

MedSource is a private company. It is classified as unknown and is currently operating.

When was MedSource founded?

MedSource was founded in 1997. It employs 51 to 100 people.

Where is MedSource based?

MedSource is headquartered in Houston, United States, in the North America region.

Who are MedSource's main competitors?

Direct peers on record are Medpace Holdings, Ergomed, Worldwide Clinical Trials, Clinipace Worldwide (now d/b/a Caidya) and Premier Research. Broad incumbents are IQVIA, Parexel International, Syneos Health, ICON plc and Labcorp Drug Development (now Fortrea).

Does MedSource have an API?

No public API is recorded for MedSource.

What industry is MedSource in?

MedSource's product category is Pharmaceutical Services. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 54171 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FierceBiotechErgomed buys up cancer, rare disease CRO MedSourceErgomed acquired U.S. CRO MedSource to expand its rare disease and oncology services, adding about $20 million in annual contracts and over $41 million in future revenue. The deal adds over 110 U.S. employees and aims to accelerate growth in the North American market.PR NewswireMedSource Receives 2020 CRO Leadership Awards for Superior Capabilities and CompatibilityMedSource received the 2020 CRO Leadership Awards for Capabilities and Compatibility from Life Science Leader and Industry Standard Research. This marks the ninth such award the company has won since the program's inception in 2012, recognizing its performance across six core categories evaluated by pharmaceutical clients. The recognition highlights MedSource's standing as a full-service clinical research organization specializing in complex study designs.PR NewswireMedSource Receives 2019 CRO Leadership Awards for Outstanding Quality and ReliabilityHouston-based MedSource has received two 2019 CRO Leadership Awards from Life Science Leader and Industry Standard Research for quality and reliability, marking the second consecutive year of this recognition. The awards were determined through a survey of 60 CROs assessed across six categories based on feedback from pharma and biopharma companies that outsource clinical trials. The recognition reinforces MedSource's position as a leading specialty CRO in the complex disease space, with particular expertise in oncology, central nervous system disorders, and rare diseases.PR NewswireMedSource Launches Staffing Solutions Division Providing Clinical, Technical, and Executive Professionals to Life Science OrganizationsMedSource, a Houston-based clinical research organization, launched a new staffing solutions division called MedSource Staffing Solutions on March 11, 2019, to provide clinical, technical, and executive professionals to life science organizations. The new division will serve biotechnology, pharmaceutical, and life science companies across early clinical development through commercialization. MedSource, recently recognized as a top 15 private life sciences company, has expanded to five offices in the United States and United Kingdom over the past five years.PR NewswireMedSource Recognized in Top 15 Private Life Science CompaniesMedSource was ranked as the #4 fastest-growing private life science company in the United States by Biospace, based on a three-year growth rate of 347 percent. The Houston-based clinical research organization also secured a spot on the Inc. 5000 list and the Houston Business Journal's Fast 100, reflecting its expansion into five offices across the US and UK.PR NewswireMedSource expands footprint, adds new service lineHouston-based Clinical Research Organization MedSource announced the expansion of its service offerings to include early-stage clinical development and pipeline planning through Investigational New Drug submissions, establishing a new Scientific Development department led by Senior Director Doris Sanchez. The company is also opening a new office at the Cambridge Innovation Center in Cambridge, MA, positioning itself within a major biotechnology hub to serve existing clients and tap into the startup ecosystem. The new services, which will be offered globally, allow MedSource to partner with biotech and pharmaceutical companies throughout the entire drug development process, from early clinical development through IND submission to clinical trial execution.PR NewswireMedSource Blazing Trail with Growth, Industry RecognitionMedSource, a Houston-based clinical research organization, has achieved 260 percent revenue growth over two years starting in 2013, growing from a specialized monitoring group to a full-service CRO with 115 employees and international offices. The company was named to the Inc. 500/5000 list for the fourth time and ranked as the sixth fastest-growing company in Houston, distinguishing itself by focusing on small- to mid-sized biotech companies in neurosciences and oncology rather than large global research programs. Looking ahead, CEO Eric Lund projects the company could grow at an average of 17 percent per year for the next five years, with plans to expand into therapeutic areas serving the aging U.S. population.PR NewswireMedSource Announces nowEDC as Electronic Data Capture Platform of ChoiceMedSource, a full-service clinical research organization, announced it has selected Datatrial's nowEDC electronic data capture platform as its preferred EDC software solution, establishing a preferred provider relationship that offers competitive pricing to MedSource's full-service clients. The partnership builds on an existing decade-long relationship between the two companies and provides MedSource's biotech clients with real-time data access, dynamic reporting, and FDA 21 CFR Part 11 compliant capabilities. Datatrial CEO Emma Banks stated the decision further strengthens their relationship for future growth, with nowEDC becoming the platform of choice across MedSource's operations.